Trial NCT04452318
Publication O'Brien M, JAMA (2022) (published paper)
Dates: 2020-07-13 to 2021-01-28
Funding: Mixed (Regeneron Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd.; COVID-19 Prevention Network (CoVPN) )
Conflict of interest: Yes